XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer

NEXT STORY
Medicenna Announces Submission of Clinical Trial Application in Australia for a Phase 1/2 Study of MDNA11
PREV STORY
$74 Billion Pain Management Drugs Global Market to 2026 – by Drug Class, Indication, Distribution Channel and Region
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioXcel Therapeutics Announces Initiation of Pivotal Phase 3 Studies of BXCL501 for Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder

author_avatar
NASDAQ Market News

Provectus Biopharmaceuticals Announces Oral Presentation of Updated Data from Combination Therapy Trial of PV-10® and Keytruda® for Checkpoint-Refractory Advanced Cutaneous Melanoma at Melanoma Bridge 2020

author_avatar
NASDAQ Market News

Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights

author_avatar
NASDAQ Market News